MediPal Holdings Corporation

TSE:7459.T

2554.5 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 3,558,7323,360,0083,290,9213,211,1733,253,1223,181,9353,146,3413,064,0413,028,2352,872,9132,947,7382,810,9142,750,2152,662,8872,545,9852,463,8072,255,0462,166,8461,921,7141,665,902
Cost of Revenue 3,325,7243,135,7033,073,4762,996,9123,016,3822,949,4332,918,2412,845,0222,810,7382,671,1782,738,3802,608,7722,557,6472,474,7402,354,8942,276,5712,063,3921,978,6111,760,1121,528,097
Gross Profit 233,008224,305217,445214,261236,740232,502228,100219,019217,497201,735209,358202,142192,568188,147191,091187,236191,654188,235161,602137,805
Gross Profit Ratio 0.0650.0670.0660.0670.0730.0730.0720.0710.0720.070.0710.0720.070.0710.0750.0760.0850.0870.0840.083
Reseach & Development Expenses 991103108106118000000000000000
General & Administrative Expenses 165,203000000000007,9027,9528,3517,4588,21013,0219,5496,868
Selling & Marketing Expenses 20,47418,80518,61718,66518,93017,34716,15416,02114,53613,67713,85713,97814,57114,68814,64514,73413,417000
SG&A 184,68618,80518,61718,66518,93017,34716,15416,02114,53613,67713,85713,97822,47322,64022,99622,19221,62713,0219,5496,868
Other Expenses 11,4469,95810,2439,1569,2359,8539,3229,1339,1898,6518,9688,50710,4629,5759,02016,08714,88614,33113,21713,829
Operating Expenses 185,677175,328171,818175,679183,625182,671183,835179,364175,211168,936174,692173,618130,418132,857131,993132,223123,366120,841106,12895,994
Operating Income 47,33148,97245,62438,57653,10949,82744,26039,65042,28332,79534,66228,51920,89013,54818,43313,45527,95027,77620,60810,986
Operating Income Ratio 0.0130.0150.0140.0120.0160.0160.0140.0130.0140.0110.0120.010.0080.0050.0070.0050.0120.0130.0110.007
Total Other Income Expenses Net 27,41021,08711,65710,65822,42313,99119,20112,79812,52012,12413,83611,378-36,347-46,652-50,410-33,430-25,149-33,055-25,366-22,507
Income Before Tax 74,74170,06157,28449,23775,53663,46163,46652,45354,80644,92348,50239,90225,8038,6388,68821,58343,13934,33930,10819,304
Income Before Tax Ratio 0.0210.0210.0170.0150.0230.020.020.0170.0180.0160.0160.0140.0090.0030.0030.0090.0190.0160.0160.012
Income Tax Expense 22,97321,73818,08715,62124,30618,03519,93016,11517,88315,82218,39717,25711,3765,4256,7299,07515,34515,2339,26610,502
Net Income 41,47438,80629,42323,92637,96834,35934,78029,01130,77123,68725,48518,65511,6501,7041,95812,51027,79419,10520,8428,729
Net Income Ratio 0.0120.0120.0090.0070.0120.0110.0110.0090.010.0080.0090.0070.0040.0010.0010.0050.0120.0090.0110.005
EPS 195.83184.82140.13113.95175.8145.15154.13128.12135.89104.73112.7782.2449.67.278.3152.3119.282.8697.6445.9
EPS Diluted 195.83179.12131.41106.8165.33145.15149.91128.12135.89104.73112.7782.2449.67.278.3152.22118.5382.2994.2243.52
EBITDA 65,31379,80576,40067,80682,84378,37874,52267,84468,10157,28463,54348,70385,85179,33982,63484,80194,48293,45377,44563,207
EBITDA Ratio 0.0180.0240.0230.0210.0250.0250.0240.0220.0220.020.0220.0170.0310.030.0320.0340.0420.0430.040.038